The Fund aims to achieve long term capital growth.
Name | % Net Assets |
---|---|
Care UK | 3.3% |
Dechra Pharmaceuticals | 3.1% |
RM | 3.1% |
Ultra Electronics Holdings | 2.9% |
Fisher (James) & Sons | 2.4% |
Chemring Group | 2.4% |
BPP Holdings | 2.3% |
Synergy Health | 2.2% |
Dignity | 2.2% |
Protherics | 2.2% |
Key | % Net Assets |
---|---|
Care UK | 3.3% |
Dechra Pharmaceuticals | 3.1% |
RM | 3.1% |
Ultra Electronics Holdings | 2.9% |
Other | 87.6% |
Date | 06-May-2010 |
---|---|
NAV | 109.56p |
Currency | GBP |
Change | -1.20p |
% | -1.08% |
YTD change | 109.56p |
YTD % | n/a |
Fund Inception | 25/01/1992 |
---|---|
Fund Manager | Ed Robinson |
TER | - |
Minimum Investment | |
---|---|
Initial | £500000 |
Additional | n/a |
Savings | £100 |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | 0.75% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.01 |
Sharpe ratio | 0.22 |
You are here: research